As the U.S. stock market faces turbulence with major indexes tumbling due to rising oil prices and Treasury yields, investors are keenly observing potential opportunities amidst the volatility. In such an environment, identifying stocks that may be trading below their estimated value can provide a strategic edge, as they offer the prospect of growth when market conditions stabilize.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
MidWestOne Financial Group (NasdaqGS:MOFG) |
$27.03 |
$53.83 |
49.8% |
|
Molina Healthcare (NYSE:MOH) |
$325.26 |
$641.75 |
49.3% |
|
Associated Banc-Corp (NYSE:ASB) |
$21.21 |
$41.76 |
49.2% |
|
Cadence Bank (NYSE:CADE) |
$31.07 |
$61.50 |
49.5% |
|
Heartland Financial USA (NasdaqGS:HTLF) |
$56.17 |
$110.14 |
49% |
|
California Resources (NYSE:CRC) |
$54.18 |
$104.21 |
48% |
|
Tenable Holdings (NasdaqGS:TENB) |
$40.44 |
$78.80 |
48.7% |
|
EVERTEC (NYSE:EVTC) |
$33.55 |
$66.42 |
49.5% |
|
Dingdong (Cayman) (NYSE:DDL) |
$3.64 |
$7.18 |
49.3% |
|
Alnylam Pharmaceuticals (NasdaqGS:ALNY) |
$266.77 |
$518.82 |
48.6% |
Underneath we present a selection of stocks filtered out by our screen.
Overview: DexCom, Inc. is a medical device company specializing in the design, development, and commercialization of continuous glucose monitoring systems globally, with a market capitalization of approximately $27.29 billion.
Operations: The company’s revenue is primarily derived from its continuous glucose monitoring systems, with the…
